The George Institute For Global Health
United Kingdom

Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules.

TitleExploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules.
Publication TypeJournal Article
Year of Publication2018
AuthorsWolley, M, Jardine, M, Hutchison, CA
JournalClin J Am Soc Nephrol
Pagination805 - 814
Date Published2018 Mar 05

<p>Dialysis technologies have continued to advance over recent decades; however, these advancements have not always been met with improved patient outcomes. In part, the high morbidity and mortality associated with dialysis have been attributed to a group of uremic toxins, which are described as "difficult to remove." With a new generation of hemodialysis membranes now making meaningful clearance of these molecules possible, it is an apt time to review the clinical relevance of these middle molecules. Our review describes the developments in membrane technology that enable the removal of large middle molecules (molecular mass >15 kD) that is limited with high-flux dialysis membranes. Of the known 58 middle molecules, a literature search identified 27 that have molecular mass >15 kD. This group contains cytokines, adipokines, hormones, and other proteins. These molecules are implicated in chronic inflammation, atherosclerosis, structural heart disease, and secondary immunodeficiency in the literature. Single-center safety and efficacy studies have identified that use of these membranes in maintenance dialysis populations is associated with limited loss of albumin and increased clearance of large middle molecules. Larger, robustly conducted, multicenter studies are now evaluating these findings. After completion of these safety and efficacy studies, the perceived clinical benefits of providing clearance of large middle molecules must be assessed in rigorously conducted, randomized clinical studies.</p>

Alternate JournalClin J Am Soc Nephrol
PubMed ID29507008